Umberto Perron

Umberto Perron has extensive work experience in the field of computational biology and bioinformatics. Umberto started their career as a Research Intern at the Computational Biology Unit, Molecular Biotechnology Center, Università degli Studi di Torino, where they developed a pipeline to retrieve and preprocess RNAseq data and used co-expression networks to annotate lncRNAs with ontology terms. Umberto then worked as a Visiting PhD Student at the Medicines Discovery Catapult, expanding their thesis work on modeling structural constraints on residue substitution in homologous proteins.

After that, Umberto joined the European Bioinformatics Institute | EMBL-EBI as a Predoc Fellow on the EMBL International PhD Programme, where they were involved in research under the supervision of Dr. Nick Goldman. During their time there, they gained expertise in the field of bioinformatics and contributed to various projects.

Later, Umberto joined Human Technopole as a Postdoctoral Researcher, where they focused on multi-omics integration for pharmacogenomics, machine learning for biomarker discovery and drug repositioning, and biomedical knowledge graphs. Umberto successfully processed and integrated multi-omics data from colorectal cancer patients and developed an ensemble machine learning classifier for targeted therapy sensitivity, outperforming existing biomarker signatures.

Currently, Umberto is working at Omniscope as a Senior Computational Biologist. The details of their role and responsibilities are not provided.

Umberto Perron pursued their education with dedication and achieved significant academic milestones. From 2016 to 2021, they attended the University of Cambridge, where they pursued a Doctor of Philosophy (PhD) in Bioinformatics. Prior to that, they completed a Master's degree in Molecular Biotechnology from the Università degli Studi di Torino, from 2014 to 2016. Umberto's academic journey began in 2011 when they obtained their Bachelor's degree in Biotechnology, also from the Università degli Studi di Torino. Through these educational experiences, they developed a strong foundation in the field of biotechnology and advanced their expertise in bioinformatics during their Ph.D.